Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04153604 · ClinicalTrials.gov registry record
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 841
- Enrollment target
NCT04153604: Completed study, sponsored by Methodist Health System.
NCT04153604 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 841 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04153604 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 841 participants
- Enrollment target
Study Summary
The utilization of doxycycline for SBP prophylaxis is a novel practice at MDMC. Therefore, an assessment of safety and efficacy is needed in order to generalize this practice. The publication of this study can potentially introduce a new alternative to guideline-directed therapies for secondary prevention of SBP. Doxycycline is non-inferior to guideline-directed therapies regarding safety and efficacy in primary and secondary prophylaxis for SBP.
Primary Outcome
Occurrence of reported SBP within 1-year of chemoprophylaxis initiation
Interventions
- DRUG doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 841 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-08-07 |
What the finished NCT04153604 record still lists
NCT04153604 is an observational study that tracks outcomes without assigning an intervention. The registered 841 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which doxycycline is the first listed.
NCT04153604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04153604 about?
NCT04153604 is a clinical study titled "Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis". The utilization of doxycycline for SBP prophylaxis is a novel practice at MDMC. Therefore, an assessment of safety and efficacy is needed in order to generalize this practice. The publication of this study can potentially introduce a new alternative to guideline-directed therapies for secondary prev...
What is the current status of trial NCT04153604?
This trial is currently completed. The enrollment target is 841 participants. The study started on 2019-11-04. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT04153604?
The interventions under investigation include: doxycycline (DRUG).
Who is sponsoring clinical trial NCT04153604?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06027788 · 842 participants · NA
CTSN Embolic Protection Trial
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI